as United States biological therapy debuts a new breakthrough in the treatment of advanced cancer. The breakthrough was what?
profile to say that the most effective methods of cancer diagnosis and treatment of bio—CIK radical operation in patients with advanced cancer cell therapies are expected to, this therapy can be precise, quick fix immune system kill cancer cells; interrupting the recurrence and metastasis, improve the quality of life, extending length of up to 15 years to life. In response, medical experts said the therapy is a wonderful work in the field of cancer treatment.
XI ‘ an international CIK cells for the treatment of traditional Chinese medical science Hospital Center to introduce the most advanced and most effective methods of diagnosis and treatment of tumor biology–CIK cell therapy. Diagnosis and treatment of the Centre took the lead in promoting the CIK cell specification and actively brings together biological diagnosis and treatment of key experts at home and abroad. In addition, in order to better help cancer patients, the centre opened a national toll-free telephone: 4,006,866,012.
through the Centre of 120 patients with tumor clinical practice has proved that the therapy could be significant inhibition of tumor cell growth, proliferation, and significantly improve patients ‘ quality of life, improve cancer patients ‘ survival was after cancer surgery, radiotherapy, chemotherapy and a new and more effective means of biological treatment.
cell therapy and other therapies differ in that it can help the body’s ability to restore to fight tumor cells, maximize the mobilization of immune function, minimizing the number of residual tumor cells in vivo, thus prolonging the survival time of patients. CIK cells known as cytokine-activated killer cells, are found in human blood lymphocytes, after some time training acquired from a immunocompetent cells. These cells are characterized by the proliferation of high speed, killing tumor activity and kill tumors inclusive, equally sensitive to multiple-antibiotic-resistant tumor cells, and the ability to recognize a very strong, like a cell missiles, aim at the destruction of tumor cells.
according to the Centre’s Director Professor Xu, whole treatment of CIK cells into peripheral blood mononuclear cell collection, in vitro and reinfusion into three parts. First blood cell separator separating all of peripheral blood monocytes in patients with, while other blood components unchanged also to patients. Isolated cells were then sent to specialized laboratories for in vitro culture and induced, get the CIK cell, 7-10 days before the proliferation of multiple cell transfusion to the patient. Whole procedure carried out in a sterile environment, ensure the security of the treatment. Accepts one of CIK cells for the treatment of liver cancer patients, occasions when larger amounts of ascites, tapping you want 1000-2000 ml per day. After receiving a CIK cell therapy, ascites growing significantly slowed down, effectively improving the quality of life.
the best is that it can kill cancer cells without harming normal cells, particularly with regard to CIK cells for the treatment of liver cancer, in all cases can achieve a good effect, mainly in the following areas: one is to alleviate the suffering of patients with liver cancer, improving the quality of life, and increased appetite, improve sleep quality, strength, weight gain. Second, the majority of cases after Interventional treatment such as surgery, or at the same time, combined with CIK cells for further clearing residual cancer cells in vitro and in vivo. Third, more than 60% of cases of fetuin is decreased, HBV DNA yin, and liver functions returned to normal. Four is the number and activity of anti-tumor immune cells in the blood significantly improve, and maintain a long time.
cell therapy can be applied to the treatment of liver cancer patients, interventional, and surgical excision, radio-therapeutic effect on patients after treatment at the same time or better. And also to adjust and enhance body immunity, play in the long-term in vivo antitumor activity, except to get rid of cancer cells in the body, it also . prevents tumor recurrence and metastasis. More important is that the CIK cell therapy on human normal cells, the immune system does not have any injuries, are a safe and reliable, no side-effects of cancer treatments. In addition, the CIK cell therapy in the medical treatment on the basis of, no surgery, embolization of stage ⅲ in patients with hepatocellular carcinoma combined treatment, so as to achieve the aim of extending patient life.
Comments are closed, but trackbacks and pingbacks are open.